2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on mUC: Can We Consider Recently FDA Approved Avelumab Maintenance a New 1st-line SoC? Is Switch Maintenance Checkpoint Inhibition Preferred Over a Treatment Break Followed by 2nd Line?

0 views
July 15, 2020
Comments 0
Login to view comments. Click here to Login